Viatris Operating Expenses 2010-2025 | VTRS

Viatris operating expenses for the twelve months ending June 30, 2025 were $16.719B, a 9.43% increase year-over-year.

  • Viatris annual operating expenses for 2024 were $14.729B, a 0.47% increase from 2023.
  • Viatris annual operating expenses for 2023 were $14.661B, a 0.09% increase from 2022.
  • Viatris annual operating expenses for 2022 were $14.648B, a 18.26% decline from 2021.

Viatris Operating Expenses 2010-2025 | VTRS

  • Viatris annual operating expenses for 2024 were $14.729B, a 0.47% increase from 2023.
  • Viatris annual operating expenses for 2023 were $14.661B, a 0.09% increase from 2022.
  • Viatris annual operating expenses for 2022 were $14.648B, a 18.26% decline from 2021.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$146B
CVS Health (CVS)$90.6B
Elevance Health (ELV)$69.7B
Cencora (COR)$58.8B
DiDi Global (DIDIY)$29.4B
Labcorp Holdings (LH)$23B
Natera (NTRA)$22.2B
BioMerieux (BMXMF)$17.5B
EUROFINS SCIENT (ERFSF)$15.5B
ICON (ICLR)$14.2B
Medpace Holdings (MEDP)$12.7B
CochLear (CHEOY)$12.7B
Solventum (SOLV)$12.5B
Caris Life Sciences,�Inc (CAI)$10.7B
Revvity (RVTY)$10.4B
Avantor (AVTR)$8.6B
Sonic Healthcare (SKHHY)$8B
HealthEquity (HQY)$7.9B
Charles River Laboratories (CRL)$7.6B
Bausch + Lomb (BLCO)$5.1B
Sotera Health (SHC)$4.5B
BrightSpring Health Services (BTSG)$4.2B
KindlyMD (NAKA)$4B
Amplifon S.p.A (AMFPF)$3.9B
GeneDx Holdings (WGS)$3.5B
Alignment Healthcare (ALHC)$3.1B
Concentras Parent (CON)$2.9B
Surgery Partners (SGRY)$2.9B
Organon (OGN)$2.4B
Premier (PINC)$2.1B